While data from a homologous booster clinical trial has now become available for Covaxin, there is no supporting data from India for Covishield. Yet, Covishield makes for up to 90% of vaccines administered to adults so far in India. On January 5, five days before the roll-out of the ‘protection dose’, scientifically called a third … Continue reading Are there clinical trial data to support a homologous vaccine booster?
Scientists in India are divided over the issue of whether young, healthy children need to be vaccinated in the absence of data showing their risk of suffering from severe disease or death. While there are certain advantages of vaccinating as many people as possible, including young, healthy children, will targeting them result in adults, who … Continue reading Should healthy children be vaccinated on priority?
As vaccines are a tool to promote health equity, all attempts should be made to remove any artificial barriers in accessing them particularly during the pandemic and more so when several States are witnessing a surge in cases. Just three weeks after India rolled out the second phase of the mass COVID-19 vaccination programme to … Continue reading Achieving vaccine equity by making comorbidities redundant for those above 45 years
The list of comorbidities approved by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been left out. The focus seems to be on people with severe diseases and combination of comorbidities. On February 27, the Health Ministry released a list of 20 comorbidities that will make a person in the … Continue reading Doctors say comorbidities list for COVID-19 vaccination is highly restrictive